CAPITAL INTERNATIONAL LTD /CA/
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1065350
LOS ANGELES, CA
Position in ALNY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,621,037
-$17,286,745 QoQ
Shares Held
29,078
-57.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $119,458,337 across 7 Biotechnology names. ALNY ranks #5 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,874 | $42,811,575 | |
| 2 | RPRX |
Royalty Pharma plc
|
570,577 | $27,370,578 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
76,515 | $22,722,659 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,610 | $10,515,630 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
29,078 | $9,621,037 | |
| 6 | ASND |
Ascendis Pharma A/S
|
16,394 | $3,749,799 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
56,066 | $2,667,059 |
All Filings in ALNY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,621,037 | 29,078 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $26,907,782 | 67,667 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $35,669,688 | 78,223 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $27,000,252 | 82,800 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $22,116,258 | 81,906 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $18,891,157 | 80,282 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,619,337 | 100,423 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $22,896,675 | 94,225 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,747,726 | 65,224 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $16,917,772 | 88,385 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,462,507 | 92,956 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,774,775 | 93,581 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,746,145 | 93,581 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,923,894 | 88,045 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,613,882 | 68,015 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,707,933 | 45,992 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,566,090 | 21,839 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||